Skip to main content
. 2023 Apr 3;13(7):1333. doi: 10.3390/diagnostics13071333

Table 2.

Differences between characteristics of the patients according to the one- or two-stent technique.

Variable Patients with One-Stent Technique (n = 163) Patients with Two-Stent Technique (n = 38) p Value
Age, years (mean ± SD) 66.8 ± 9.9 65.3 ± 10.1 0.41
Male gender (n,%) 115 (71) 27 (75) 0.63
Risk factors
Arterial hypertension (n,%) 147 (90.7) 36 (100) 0.06
Obesity (n,%) 47 (29) 10 (27.8) 0.87
Smoking (n,%) 21 (13) 7 (19.4) 0.33
Dyslipidemia (n,%) 137 (84.6) 33 (91.7) 0.30
Diabetes (n,%) 60 (37) 14 (38.9) 0.85
Preprocedural characteristics
LM area IVUS/OCT, mm2 (mean ± SD) 3.81 ± 1.36 4.17 ± 0.94 0.16
QCA—LM (mean ± SD) 83.3 ± 10.7 80.4 ± 11 0.17
LVEF before PCI (mean ± SD) 49.4 ± 7.7 47.6 ± 9.14 0.22
Intraprocedural characteristics
Number of patients with intermediate SYNTAX score (n,%) 46 (28.4) 25 (69.4) <0.0001
Number of patients with kissing-balloon inflation technique (n,%) 49 (30) 25 (69.4) <0.0001
Number of patients with POT (n,%) 147 (90.7) 30 (83.3) 0.19
FFR in the SB 39 (23.9) 12 (31.5) 0.44
FFR-side branch (mean ± SD) (median [average rank]) 0.9 [73.9] 0.89 [62.8] 0.23
Number of patients with FFR >0.8 (n,%) 111 (68.5) 24 (66.6) 0.83
SESBL, mm (median [IQR]) 2.5 [77.3] 2.55 [7.4] 0.91
Number of patients with SESBL >2 (n,%) 91 (56.2) 17 (47.2) 0.33
Intraprocedural complications (%) 14 (8.6) 5 (13.9) 0.79
Postprocedural characteristics
Necessity of inotropic/vasopressor medication during hospitalization (n,%) 4 (2.4) 1 (2.7) 0.91
Necessity of IABP (n,%) 0 (0) 0 (0) 0
Number of days of admission (mean ± SD) 3.4 ± 3 4.2 ± 4 0.22
LVEF after PCI (mean ± SD) 49.8 ± 8.14 48.6 ± 16.3 0.55

FFR, fractional flow reserve; IABP, intra-aortic balloon pump therapy; IVUS, intravascular ultrasound; LM, left main; LVEF, left ventricular ejection fraction; NSTEMI, non-ST elevation myocardial infarction; OCT, optical coherence tomography; PCI, percutaneous coronary intervention; POT, proximal optimization technique; STEMI, ST-elevation myocardial infarction.